CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 62 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,594,153 | +133.7% | 53,603 | +41.6% | 0.00% | – |
Q2 2023 | $682,020 | +88.3% | 37,848 | +67.9% | 0.00% | – |
Q1 2023 | $362,104 | +24.1% | 22,547 | +41.4% | 0.00% | – |
Q4 2022 | $291,812 | -2.7% | 15,946 | +4.5% | 0.00% | – |
Q3 2022 | $300,000 | +11.5% | 15,261 | +5.8% | 0.00% | – |
Q2 2022 | $269,000 | -14.1% | 14,430 | +1.3% | 0.00% | – |
Q1 2022 | $313,000 | -20.4% | 14,241 | +2.8% | 0.00% | – |
Q4 2021 | $393,000 | +94.6% | 13,851 | +44.6% | 0.00% | – |
Q3 2021 | $202,000 | +110.4% | 9,576 | +88.0% | 0.00% | – |
Q2 2021 | $96,000 | +50.0% | 5,093 | +20.3% | 0.00% | – |
Q1 2021 | $64,000 | +12.3% | 4,235 | +5.7% | 0.00% | – |
Q4 2020 | $57,000 | -9.5% | 4,005 | 0.0% | 0.00% | – |
Q3 2020 | $63,000 | -30.0% | 4,005 | -21.9% | 0.00% | – |
Q2 2020 | $90,000 | +221.4% | 5,129 | +174.0% | 0.00% | – |
Q1 2020 | $28,000 | -48.1% | 1,872 | -17.2% | 0.00% | – |
Q4 2019 | $54,000 | +92.9% | 2,262 | +22.7% | 0.00% | – |
Q3 2019 | $28,000 | -39.1% | 1,843 | 0.0% | 0.00% | – |
Q2 2019 | $46,000 | +39.4% | 1,843 | +26.0% | 0.00% | – |
Q1 2019 | $33,000 | +6.5% | 1,463 | +38.9% | 0.00% | – |
Q4 2018 | $31,000 | +3.3% | 1,053 | 0.0% | 0.00% | – |
Q3 2018 | $30,000 | – | 1,053 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 3,375,169 | $84,379,000 | 7.91% |
RA Capital Management | 1,875,209 | $46,880,000 | 2.52% |
Perceptive Advisors | 2,587,953 | $64,698,000 | 1.48% |
New Leaf Venture Partners, L.L.C. | 167,700 | $4,193,000 | 1.12% |
Orbimed Advisors | 2,039,282 | $50,982,000 | 0.79% |
Eventide Asset Management | 803,839 | $20,096,000 | 0.61% |
Novo Holdings A/S | 135,009 | $3,375,000 | 0.47% |
Opaleye Management Inc. | 36,000 | $900,000 | 0.27% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 490,000 | $12,250,000 | 0.03% |
Baker Brothers Advisors | 132,985 | $3,325,000 | 0.02% |